Publications by authors named "Tadeusz Robak"

100Publications

Skin changes in hairy cell leukemia.

Ann Hematol 2020 Nov 20. Epub 2020 Nov 20.

Department of Hematology, Medical University of Lodz, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04349-zDOI Listing
November 2020

The safety of available chemo-free treatments for mantle cell lymphoma.

Expert Opin Drug Saf 2020 Nov 5;19(11):1377-1393. Epub 2020 Oct 5.

Department of Hematology, Medical University of Lodz , Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2020.1826435DOI Listing
November 2020

Bone lesions in hairy cell leukemia: Diagnosis and treatment.

Eur J Haematol 2020 Dec 19;105(6):682-691. Epub 2020 Aug 19.

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13505DOI Listing
December 2020

Multifocal osteolytic lesions in hairy cell leukemia-the importance of PET/CT in diagnosis and assessment.

Ann Hematol 2020 Jun 12. Epub 2020 Jun 12.

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Ul. Ciolkowskiego 2, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04121-3DOI Listing
June 2020

Investigational treatments for chronic lymphocytic leukemia: a focus on phase 1 and 2 clinical trials.

Expert Opin Investig Drugs 2020 Jul 27;29(7):709-722. Epub 2020 May 27.

Department of Hematology, Copernicus Memorial Hospital, Lodz, Medical University of Lodz , Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2020.1770225DOI Listing
July 2020

The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia.

Expert Opin Biol Ther 2020 Jul 3;20(7):799-812. Epub 2020 Mar 3.

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital , Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2020.1734557DOI Listing
July 2020

Minimizing and managing treatment-associated complications in patients with chronic lymphocytic leukemia.

Expert Rev Hematol 2020 01 30;13(1):39-53. Epub 2019 Nov 30.

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2020.1696185DOI Listing
January 2020

A large single-institution retrospective analysis of aggressive B-cell lymphomas according to the 2016/2017 WHO classification.

Adv Clin Exp Med 2019 Oct;28(10):1359-1365

Department of Pathology, Chair of Oncology, Medical University of Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17219/acem/109200DOI Listing
October 2019

Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs.

Eur J Haematol 2019 Dec 18;103(6):531-541. Epub 2019 Sep 18.

Copernicus Memorial Hospital, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13319DOI Listing
December 2019

Glasdegib in the treatment of acute myeloid leukemia.

Future Oncol 2019 Oct 21;15(28):3219-3232. Epub 2019 Aug 21.

Department of Hematology, Medical University of Lodz, ul. Ciolkowskiego 2, 93-510 Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0171DOI Listing
October 2019

Clinical management of mantle cell lymphoma in the elderly.

Expert Opin Pharmacother 2019 Oct 2;20(15):1893-1905. Epub 2019 Aug 2.

Department of Hematology, Medical University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2019.1642871DOI Listing
October 2019

Moxetumomab pasudotox for the treatment of hairy cell leukemia.

Expert Opin Biol Ther 2019 06 10;19(6):501-508. Epub 2019 May 10.

a Department of Hematology , Medical University of Lodz and Copernicus Memorial Hospital , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2019.1614558DOI Listing
June 2019

Mantle cell lymphoma: therapeutic options in transplant-ineligible patients.

Leuk Lymphoma 2019 11 25;60(11):2622-2634. Epub 2019 Apr 25.

Department of Medicine III, University Hospital Ludwig Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2019.1605511DOI Listing
November 2019

Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later.

Drugs R D 2019 Jun;19(2):73-92

Department of Hematology, Medical University of Lodz, Ul. Ciolkowskiego 2, 93-510, Lodz, Poland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40268-019-0269-9
Publisher Site
http://dx.doi.org/10.1007/s40268-019-0269-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544598PMC
June 2019

Venetoclax in the treatment of chronic lymphocytic leukemia.

Expert Opin Drug Metab Toxicol 2019 May 25;15(5):353-366. Epub 2019 Apr 25.

a Department of Hematology , Medical University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2019.1606211DOI Listing
May 2019

The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia.

Arch Immunol Ther Exp (Warsz) 2019 Apr 28;67(2):109-123. Epub 2019 Feb 28.

Department of Hematology, Medical University, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-019-00535-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420492PMC
April 2019

Safety and Tolerability of Antibody-Drug Conjugates in Cancer.

Drug Saf 2019 02;42(2):295-314

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Ul. Ciolkowskiego 2, 93-510, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40264-018-0775-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399172PMC
February 2019

Concurrent treatment with two B-cell receptor pathway inhibitors.

Authors:
Tadeusz Robak

Lancet Haematol 2019 01 14;6(1):e8-e9. Epub 2018 Dec 14.

Department of Hematology, Medical University of Lodz, 93-510 Lodz, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30212-6DOI Listing
January 2019

Drug resistance in multiple myeloma.

Cancer Treat Rev 2018 Nov 4;70:199-208. Epub 2018 Sep 4.

Department of Hematology, Medical University of Lodz, Lodz, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.09.001DOI Listing
November 2018

The efficacy of sapacitabine in treating patients with acute myeloid leukemia.

Expert Opin Pharmacother 2018 Nov 24;19(16):1835-1839. Epub 2018 Sep 24.

a Department of Hematology , Medical University of Lodz and Copernicus Memorial Hospital , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2018.1524875DOI Listing
November 2018

Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

N Engl J Med 2018 Mar;378(12):1107-1120

From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) - all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) - both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne-Bonn, Cologne, Germany (B.E.); St. James's University Hospital, Leeds (P.H.), and F. Hoffmann-La Roche, Welwyn Garden City (M.B., K.H.) - both in the United Kingdom; Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal (S.A.), and the Departments of Medicine and Oncology, University of Calgary, Calgary, AB (C.O.) - all in Canada; Memorial Sloan Kettering Cancer Center, New York (J.G.); the Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland (T.R.); Hospital Universitario 12 de Octubre, Madrid (J.D.S.); Medical University of Vienna, Department of Medicine I, Division of Hematology and Hemostaseology, Vienna (U.J.); the Department of Hematology, Centre Hospitalier Universitaire Montpellier, Montpellier, France (G.C.); the Department of Onco-Hematology, Division of Hematology, Niguarda Cancer Center, Niguarda Hospital, Milan (M. Montillo); AbbVie, North Chicago, IL (R.H.); and the Department of Hematology, Cancer Center Amsterdam, Academic Medical Center, Amsterdam (A.P.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1713976DOI Listing
March 2018

miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment.

Eur J Haematol 2018 May 27;100(5):426-435. Epub 2018 Feb 27.

Department of Hematology, Comprehensive Cancer Center and Traumatology, Copernicus Memorial Hospital in Lodz, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13036DOI Listing
May 2018

Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies.

Expert Opin Investig Drugs 2018 02 15;27(2):171-177. Epub 2018 Jan 15.

b Department of Hematology , Medical University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2018.1427730DOI Listing
February 2018

promoter methylation as a potential prognostic marker for acute leukemia.

Arch Med Sci 2017 Oct 31;13(6):1433-1441. Epub 2017 Oct 31.

Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, Rzeszow, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2017.71067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701700PMC
October 2017

VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment.

Ann Hematol 2017 Dec 27;96(12):2103-2112. Epub 2017 Sep 27.

Department of Hematology, Copernicus Memorial Hospital in Lodz Comprehensive Cancer and Traumatology Center, Pabianicka 62, 93-513, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3133-4DOI Listing
December 2017

Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia.

Expert Opin Investig Drugs 2017 Nov 3;26(11):1249-1265. Epub 2017 Oct 3.

b Department of Hematology , Medical University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1384814DOI Listing
November 2017

Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized clinical trials.

Leuk Lymphoma 2018 05 11;59(5):1084-1094. Epub 2017 Sep 11.

a Department of Hematology , Medical University of Lodz, Copernicus Memorial Hospital , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1375101DOI Listing
May 2018

Will combination therapy with targeted drugs be better for achieving remission in chronic lymphocytic leukemia?

Authors:
Tadeusz Robak

Expert Opin Pharmacother 2017 11 1;18(16):1675-1678. Epub 2017 Sep 1.

a Department of Hematology , Medical University of Lodz, Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1373094DOI Listing
November 2017

Emerging antibody-drug conjugates for treating lymphoid malignancies.

Expert Opin Emerg Drugs 2017 09 28;22(3):259-273. Epub 2017 Aug 28.

a Department of Hematology , Medical University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2017.1366447DOI Listing
September 2017

Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.

Macromol Biosci 2017 11 1;17(11). Epub 2017 Aug 1.

Department of Clinical and Laboratory Genetics, Medical University of Lodz, Pomorska Str. 251, 92-213, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mabi.201700130DOI Listing
November 2017

The discovery and development of romidepsin for the treatment of T-cell lymphoma.

Expert Opin Drug Discov 2017 08 22;12(8):859-873. Epub 2017 Jun 22.

b Department of Hematology , Medical University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2017.1341487DOI Listing
August 2017

The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia.

Tumour Biol 2017 Mar;39(3):1010428317694551

1 Department of Experimental Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1010428317694551DOI Listing
March 2017

Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia.

Postepy Hig Med Dosw (Online) 2016 12 30;70(0):1321-1330. Epub 2016 Dec 30.

Department of Hematology, Copernicus Memorial Hospital Medical University of Lodz, Poland; Copernicus Memorial Hospital, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/17322693.1227556DOI Listing
December 2016

Front-line treatment of CLL in the era of novel agents.

Cancer Treat Rev 2017 Feb 30;53:70-78. Epub 2016 Dec 30.

Department of Hematology, Niguarda Cancer Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.12.007DOI Listing
February 2017

The safety profile of monoclonal antibodies for chronic lymphocytic leukemia.

Expert Opin Drug Saf 2017 Feb 4;16(2):185-201. Epub 2016 Dec 4.

a Department of Hematology Medical , University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1264387DOI Listing
February 2017

In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification.

Bioorg Med Chem 2016 11 20;24(21):5076-5087. Epub 2016 Aug 20.

Laboratory of Molecular Virology and Biological Chemistry, Institute of Medical Biology Polish Academy of Sciences, Lodowa 106, 92-232 Łódź, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2016.08.028DOI Listing
November 2016

Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done?

Expert Opin Drug Discov 2016 Nov 7;11(11):1033-1045. Epub 2016 Sep 7.

b Department of Hematology , Medical University of Lodz , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2016.1230095DOI Listing
November 2016

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.

Molecules 2016 Jul 30;21(8). Epub 2016 Jul 30.

Department of Experimental Hematology of Medical University of Lodz, Ciołkowskiego 2 Street, Lodz 93-510, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules21080995DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274336PMC
July 2016

Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.

Semin Oncol 2016 Apr 8;43(2):280-90. Epub 2016 Feb 8.

Department of Experimental Hematology, Medical University of Lodz, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.02.010DOI Listing
April 2016

Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.

Leuk Lymphoma 2016 09 16;57(9):2047-57. Epub 2016 Mar 16.

a Davidoff Center, Rabin Medical Center , Institute of Hematology, Beilinson Hospital , Petah Tikva , Israel ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1154956DOI Listing
September 2016

Management of Multiple Myeloma with Second-Generation Antibody-Drug Conjugates.

BioDrugs 2016 Apr;30(2):87-93

Department of Hematology, Medical University of Lodz, Ul. Ciolkowskiego 2, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-016-0165-6DOI Listing
April 2016

Novel therapies under investigation for mantle cell lymphoma.

Authors:
Tadeusz Robak

Expert Opin Investig Drugs 2016 23;25(4):375-80. Epub 2016 Feb 23.

a Department of Hematology , Medical University of Lodz, Copernicus Memorial Hospital , Lodz , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2016.1152259DOI Listing
December 2016

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma.

Arch Immunol Ther Exp (Warsz) 2016 Jun 14;64(3):225-40. Epub 2015 Dec 14.

Department of Hematology, Institute of Hematology and Transfusion Medicine, Indiry Gandhi 14, 02-776, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-015-0372-8DOI Listing
June 2016

Ibrutinib in chronic lymphocytic leukaemia: alone or in combination?

Authors:
Tadeusz Robak

Lancet Oncol 2016 Feb 5;17(2):129-131. Epub 2015 Dec 5.

Department of Hematology, Medical University of Lodz, 93-510 Lodz, Ul Ciolkowskiego 2, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00519-7DOI Listing
February 2016

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.

N Engl J Med 2015 Dec 6;373(25):2425-37. Epub 2015 Dec 6.

From the University of Texas MD Anderson Cancer Center, Houston (J.A.B.); Azienda Ospedaliera Niguarda Cà Granda (A.T.) and Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele (P.G.), Milan, and the Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara (G.G.) - all in Italy; Wilmot Cancer Institute, University of Rochester, Rochester, NY (P.M.B.); Medical University of Lodz and Copernicus Memorial Hospital, Lodz (T.R.), the Department of Cancer Prevention, School of Public Health, Medical University of Silesia, Katowice (S.G.), and the Department of Hematology, University Clinical Center of Medical University of Gdansk, Gdansk (A.H.) - all in Poland; Tom Baker Cancer Centre, Calgary, AB, Canada (C.O.); Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (O.B.), and Hadassah University Hospital, Hebrew University Medical School, Jerusalem (A.P.) - both in Israel; Leeds Teaching Hospitals, St. James Institute of Oncology, Leeds (P.H.), Kings College Hospital, London (S.D.), Royal Bournemouth Hospital, Bournemouth (H.M.), and University of Oxford, Oxford (A.S.) - all in the United Kingdom; Washington University School of Medicine, St. Louis (N.L.B.); Jiangsu Province Hospital, Nanjing, China (J.L.); North Shore Hospital, Auckland, New Zealand (D. Simpson); Stanford University School of Medicine, Stanford (S.C.), City of Hope National Medical Center, Duarte (T.S.), Pharmacyclics, Sunnyvale (D. Suri, M.C., F.C., L.S., D.F.J.), and Moores Cancer Center, University of California, San Diego, San Diego (T.J.K.) - all in California; St. Vincent's Hospital, University of Melbourne (H.Q.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital (C.S.T.), Melbourne, VIC, Australia; Institute of Blood Pathology and Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, Ukraine (Z.M.); Norton Cancer Institute, Louisville, KY (D.A.S.);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1509388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722809PMC
December 2015